Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials.

Bieber, Thomas; Katoh, Norito; Simpson, Eric L; de Bruin-Weller, Marjolein; Thaçi, Diamant; Torrelo, Antonio; Sontag, Angelina; Grond, Susanne; Issa, Maher; Lu, Xiaoyu; Cardillo, Tracy; Holzwarth, Katrin; Thyssen, Jacob P

Bieber, Thomas; Katoh, Norito; Simpson, Eric L; de Bruin-Weller, Marjolein; Thaçi, Diamant; Torrelo, Antonio; Sontag, Angelina; Grond, Susanne; Issa, Maher; Lu, Xiaoyu; Cardillo, Tracy; Holzwarth, Katrin; Thyssen, Jacob P.

Afiliação

Bieber T; Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany.
Katoh N; Christine Kühne - Center for Allergy Research and Education, Davos, Switzerland.
Simpson EL; Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
de Bruin-Weller M; Department of Dermatology, Oregon Health & Science University, Portland, OR, USA.
Thaçi D; Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, The Netherlands.
Torrelo A; Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany.
Sontag A; Department of Dermatology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.
Grond S; Eli Lilly and Company, Indianapolis, IN, USA.
Issa M; Eli Lilly and Company, Indianapolis, IN, USA.
Lu X; Eli Lilly and Company, Indianapolis, IN, USA.
Cardillo T; TechData Service Company, King of Prussia, PA, USA.
Holzwarth K; Eli Lilly and Company, Indianapolis, IN, USA.
Thyssen JP; Eli Lilly and Company, Indianapolis, IN, USA.

J Dermatolog Treat ; 34(1): 2161812, 2023 Dec.

Article em En | MEDLINE | ID: mdl-36546346

Assuntos

Azetidinas; Dermatite Atópica; Inibidores de Janus Quinases; Neoplasias; Adulto; Humanos; Dermatite Atópica/tratamento farmacológico; Azetidinas/efeitos adversos; Sulfonamidas/efeitos adversos; Inibidores de Janus Quinases/efeitos adversos; Neoplasias/induzido quimicamente; Resultado do Tratamento

Palavras-chave

Atopic dermatitis; baricitinib; long-term safety

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azetidinas / Dermatite Atópica / Inibidores de Janus Quinases / Neoplasias Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google